<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>hiv aids</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>hiv aids | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
Authors: Duncan, M. C.; Omondi, F. H.; Kinloch, N. N.; Lapointe, H. R.; Speckmaier, S.; Moran Garcia, N.; Lawson, T.; DeMarco, M. L.; Simons, J.; Holmes, D. T.; Lowe, C. F.; Bacani, N.; Sereda, P.; Barrios, R.; Harris, M.; Romney, M. G.; Montaner, J. S. G.; Brumme, C. J.; Brockman, M. A.; Brumme, Z. L.
Score: 15.1, Published: 2023-10-09 DOI: 10.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/hiv-aids/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="hiv aids" />
<meta property="og:description" content="Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
Authors: Duncan, M. C.; Omondi, F. H.; Kinloch, N. N.; Lapointe, H. R.; Speckmaier, S.; Moran Garcia, N.; Lawson, T.; DeMarco, M. L.; Simons, J.; Holmes, D. T.; Lowe, C. F.; Bacani, N.; Sereda, P.; Barrios, R.; Harris, M.; Romney, M. G.; Montaner, J. S. G.; Brumme, C. J.; Brockman, M. A.; Brumme, Z. L.
Score: 15.1, Published: 2023-10-09 DOI: 10." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/hiv-aids/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-10-25T10:39:04+00:00" />
<meta property="article:modified_time" content="2023-10-25T10:39:04+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="hiv aids"/>
<meta name="twitter:description" content="Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
Authors: Duncan, M. C.; Omondi, F. H.; Kinloch, N. N.; Lapointe, H. R.; Speckmaier, S.; Moran Garcia, N.; Lawson, T.; DeMarco, M. L.; Simons, J.; Holmes, D. T.; Lowe, C. F.; Bacani, N.; Sereda, P.; Barrios, R.; Harris, M.; Romney, M. G.; Montaner, J. S. G.; Brumme, C. J.; Brockman, M. A.; Brumme, Z. L.
Score: 15.1, Published: 2023-10-09 DOI: 10."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "hiv aids",
      "item": "https://trxiv.yorks0n.com/posts/hiv-aids/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "hiv aids",
  "name": "hiv aids",
  "description": "Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size\nAuthors: Duncan, M. C.; Omondi, F. H.; Kinloch, N. N.; Lapointe, H. R.; Speckmaier, S.; Moran Garcia, N.; Lawson, T.; DeMarco, M. L.; Simons, J.; Holmes, D. T.; Lowe, C. F.; Bacani, N.; Sereda, P.; Barrios, R.; Harris, M.; Romney, M. G.; Montaner, J. S. G.; Brumme, C. J.; Brockman, M. A.; Brumme, Z. L.\nScore: 15.1, Published: 2023-10-09 DOI: 10.",
  "keywords": [
    
  ],
  "articleBody": " Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size\nAuthors: Duncan, M. C.; Omondi, F. H.; Kinloch, N. N.; Lapointe, H. R.; Speckmaier, S.; Moran Garcia, N.; Lawson, T.; DeMarco, M. L.; Simons, J.; Holmes, D. T.; Lowe, C. F.; Bacani, N.; Sereda, P.; Barrios, R.; Harris, M.; Romney, M. G.; Montaner, J. S. G.; Brumme, C. J.; Brockman, M. A.; Brumme, Z. L.\nScore: 15.1, Published: 2023-10-09 DOI: 10.1101/2023.10.08.23296718\nObjectiveThe immunogenic nature of COVID-19 mRNA vaccines led to some initial concern that these could stimulate the HIV reservoir. We analyzed changes in plasma HIV loads (pVL) and reservoir size following COVID-19 mRNA vaccination in 62 people with HIV (PWH) receiving antiretroviral therapy (ART), and analyzed province-wide trends in pVL before and after the mass vaccination campaign. DesignLongitudinal observational cohort and province-wide analysis. Methods62 participants were sampled pre-vaccination, and one month after their first and second COVID-19 immunizations. Vaccine-induced anti-SARS-CoV-2-Spike antibodies in serum were measured using the Roche Elecsys Anti-S assay. HIV reservoirs were quantified using the Intact Proviral DNA Assay; pVL were measured using the cobas 6800 (LLOQ:20 copies/mL). The province-wide analysis included all 290,401 pVL performed in British Columbia, Canada between 2012-2022. ResultsPre-vaccination, the median intact reservoir size was 77 (IQR:20-204) HIV copies/million CD4+ T-cells, compared to 74 (IQR:27-212) and 65 (IQR:22-174) post-first and -second dose, respectively (all comparisons p\u003e0.07). Pre-vaccination, 82% of participants had pVL\u003c20 copies/mL (max:110 copies/mL), compared to 79% post-first dose (max:183 copies/mL) and 85% post-second dose (max:79 copies/mL) (p\u003e0.4). The magnitude of the vaccine-elicited anti-SARS-CoV-2-Spike antibody response did not correlate with changes in reservoir size nor detectable pVL frequency (p\u003e0.6). We found no evidence linking the COVID-19 mass vaccination campaign to population-level increases in detectable pVL frequency among all PWH in the province, nor among those who maintained pVL suppression on ART. ConclusionWe found no evidence that COVID-19 mRNA vaccines induced changes in HIV reservoir size nor plasma viremia.\nNew POCT instrument, GBTsol ICA system for HIV monitoring by CD4 and CD8 enumeration in resource-poor settings\nAuthors: aghamoradi, s.; Sung, S.; Kim, H.-S.; Song, J.; Lee, J.; Baek, S.\nScore: 1.2, Published: 2023-10-13 DOI: 10.1101/2023.10.12.23296940\nAccording to WHO report 39.0 million (33.1-45.7 million) people around the world were living with HIV infection till Dec of 2022. One method that we need for treatment and monitoring of HIV patients is CD4 counting and CD4/CD8 ratio. For this purpose, there are many different laboratory test with technical complexity and in other hand most of them are time consuming, expensive or cannot be used in resource limited places. This work demonstrates POCT microchip platform for enumerating leukocytes, CD4+ T- lymphocytes, and CD8+ T lymphocytes from whole blood, using fluorochrome-conjugated primary antibodies as a detection method. This device and its method omits all obstacles for WBC and CD4, CD8 T lymphocytes and it offers fast, cost effective and easy absolute WBC and CD4, CD8 T lymphocytes count for monitoring HIV patients immune situation with high accuracy which can be implemented insource limited stings or doctors office. We incubated Phycoerythrin (PE) conjugated primary antibodies specific to CD4 and CD8 antigens to enumerate CD4+ and CD8+ T cells, respectively. Comparison studies were performed with FACS count to evaluate total leukocytes, CD4+T cell number, and CD8+T cell number in whole blood samples for monitoring the immune systems of patients with human immunodeficiency virus (HIV)/AIDS. Statistical analyses for precision, correlation, and agreement were performed. Coefficients of variation (CV) ranging from 0.67% to 12.78%, 0.81 to 13.68%, and 0.29% to 8.33% were obtained for CD4, CD8 and leukocyte recovery respectively. A significant correlation was found between the two assays for CD4 count and CD8 count, with correlation coefficients of 0.90 and 0.91, respectively. Using Bland-Altman plots, a mean bias of 23, 38, and 490 cells/{micro}L (95% CI, n=113) was obtained for CD4, CD8, and total leukocyte count, respectively. These data show that the GBTsol ICA (Immune Cell Analyzer) is comparable to the FACS count platform method for measuring the amounts of CD4 T cells, CD8 T cells, and total leukocytes in blood samples for the purpose of monitoring HIV/AIDS patients with cheap, easy and fast way.\n",
  "wordCount" : "685",
  "inLanguage": "en",
  "datePublished": "2023-10-25T10:39:04Z",
  "dateModified": "2023-10-25T10:39:04Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/hiv-aids/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      hiv aids
    </h1>
    <div class="post-meta"><span>updated on October 25, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.08.23296718">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.08.23296718" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.08.23296718">
        <p class="paperTitle">Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.08.23296718" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.08.23296718" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Duncan, M. C.; Omondi, F. H.; Kinloch, N. N.; Lapointe, H. R.; Speckmaier, S.; Moran Garcia, N.; Lawson, T.; DeMarco, M. L.; Simons, J.; Holmes, D. T.; Lowe, C. F.; Bacani, N.; Sereda, P.; Barrios, R.; Harris, M.; Romney, M. G.; Montaner, J. S. G.; Brumme, C. J.; Brockman, M. A.; Brumme, Z. L.</p>
        <p class="info">Score: 15.1, Published: 2023-10-09 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.08.23296718' target='https://doi.org/10.1101/2023.10.08.23296718'> 10.1101/2023.10.08.23296718</a></p>
        <p class="abstract">ObjectiveThe immunogenic nature of COVID-19 mRNA vaccines led to some initial concern that these could stimulate the HIV reservoir. We analyzed changes in plasma HIV loads (pVL) and reservoir size following COVID-19 mRNA vaccination in 62 people with HIV (PWH) receiving antiretroviral therapy (ART), and analyzed province-wide trends in pVL before and after the mass vaccination campaign.

DesignLongitudinal observational cohort and province-wide analysis.

Methods62 participants were sampled pre-vaccination, and one month after their first and second COVID-19 immunizations. Vaccine-induced anti-SARS-CoV-2-Spike antibodies in serum were measured using the Roche Elecsys Anti-S assay. HIV reservoirs were quantified using the Intact Proviral DNA Assay; pVL were measured using the cobas 6800 (LLOQ:20 copies/mL). The province-wide analysis included all 290,401 pVL performed in British Columbia, Canada between 2012-2022.

ResultsPre-vaccination, the median intact reservoir size was 77 (IQR:20-204) HIV copies/million CD4&#43; T-cells, compared to 74 (IQR:27-212) and 65 (IQR:22-174) post-first and -second dose, respectively (all comparisons p&gt;0.07). Pre-vaccination, 82% of participants had pVL&lt;20 copies/mL (max:110 copies/mL), compared to 79% post-first dose (max:183 copies/mL) and 85% post-second dose (max:79 copies/mL) (p&gt;0.4). The magnitude of the vaccine-elicited anti-SARS-CoV-2-Spike antibody response did not correlate with changes in reservoir size nor detectable pVL frequency (p&gt;0.6). We found no evidence linking the COVID-19 mass vaccination campaign to population-level increases in detectable pVL frequency among all PWH in the province, nor among those who maintained pVL suppression on ART.

ConclusionWe found no evidence that COVID-19 mRNA vaccines induced changes in HIV reservoir size nor plasma viremia.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.12.23296940">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.12.23296940" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.12.23296940">
        <p class="paperTitle">New POCT instrument, GBTsol ICA system for HIV monitoring by CD4 and CD8 enumeration in resource-poor settings</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.12.23296940" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.12.23296940" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: aghamoradi, s.; Sung, S.; Kim, H.-S.; Song, J.; Lee, J.; Baek, S.</p>
        <p class="info">Score: 1.2, Published: 2023-10-13 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.12.23296940' target='https://doi.org/10.1101/2023.10.12.23296940'> 10.1101/2023.10.12.23296940</a></p>
        <p class="abstract">According to WHO report 39.0 million (33.1-45.7 million) people around the world were living with HIV infection till Dec of 2022. One method that we need for treatment and monitoring of HIV patients is CD4 counting and CD4/CD8 ratio. For this purpose, there are many different laboratory test with technical complexity and in other hand most of them are time consuming, expensive or cannot be used in resource limited places.

This work demonstrates POCT microchip platform for enumerating leukocytes, CD4&#43; T- lymphocytes, and CD8&#43; T lymphocytes from whole blood, using fluorochrome-conjugated primary antibodies as a detection method.

This device and its method omits all obstacles for WBC and CD4, CD8 T lymphocytes and it offers fast, cost effective and easy absolute WBC and CD4, CD8 T lymphocytes count for monitoring HIV patients immune situation with high accuracy which can be implemented insource limited stings or doctors office.

We incubated Phycoerythrin (PE) conjugated primary antibodies specific to CD4 and CD8 antigens to enumerate CD4&#43; and CD8&#43; T cells, respectively. Comparison studies were performed with FACS count to evaluate total leukocytes, CD4&#43;T cell number, and CD8&#43;T cell number in whole blood samples for monitoring the immune systems of patients with human immunodeficiency virus (HIV)/AIDS. Statistical analyses for precision, correlation, and agreement were performed. Coefficients of variation (CV) ranging from 0.67% to 12.78%, 0.81 to 13.68%, and 0.29% to 8.33% were obtained for CD4, CD8 and leukocyte recovery respectively. A significant correlation was found between the two assays for CD4 count and CD8 count, with correlation coefficients of 0.90 and 0.91, respectively. Using Bland-Altman plots, a mean bias of 23, 38, and 490 cells/{micro}L (95% CI, n=113) was obtained for CD4, CD8, and total leukocyte count, respectively. These data show that the GBTsol ICA (Immune Cell Analyzer) is comparable to the FACS count platform method for measuring the amounts of CD4 T cells, CD8 T cells, and total leukocytes in blood samples for the purpose of monitoring HIV/AIDS patients with cheap, easy and fast way.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
